Structural basis for midbody targeting of spastin by the ESCRT-III protein CHMP1B

Nature Structural and Molecular Biology

Volumn 15, Issue 12, 2008, Pages 1278-1286

  Yang, Dong ^a   Rismanchi, Neggy ^b   Renvoisé, Benoît ^b   Lippincott Schwartz, Jennifer ^c   Blackstone, Craig ^b   Hurley, James H ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; CHARGED MULTIVESICULAR BODY PROTEIN 1B; DNA; ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT III PROTEIN; GLUTATHIONE TRANSFERASE; IMIDAZOLE; PROTEIN; SMALL INTERFERING RNA; SPASTIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; COMPLEX FORMATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYTOKINESIS; ENDOSOME; ESCHERICHIA COLI; HELA CELL; HUMAN; HUMAN CELL; HYDROGEN BOND; MEMBRANE TRANSPORT; MEMBRANE VESICLE; MICROTUBULE; MOLECULAR CLONING; MOLECULAR INTERACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; SURFACE PLASMON RESONANCE; TWO HYBRID SYSTEM; YEAST;

ADENOSINE TRIPHOSPHATASES; BINDING SITES; CODON, NONSENSE; CRYSTALLOGRAPHY, X-RAY; HELA CELLS; HUMANS; MICROSCOPY, CONFOCAL; MODELS, BIOLOGICAL; MODELS, MOLECULAR; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 57149085245     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.1512     Document Type: Article

References (39)

1. Saksena, S., Sun, J., Chu, T. & Emr, S.D. ESCRTing proteins in the endocytic pathway. Trends Biochem. Sci. 32, 561-573 (2007).
2. Hurley, J.H. ESCRT complexes and the biogenesis of multivesicular bodies. Curr. Opin. Cell Biol. 20, 4-11 (2008).
3. Morita, E. & Sundquist, W.I. Retrovirus budding. Annu. Rev. Cell Dev. Biol. 20, 395-425 (2004).
4. Carlton, J.G. & Martin-Serrano, J. Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery. Science 316, 1908-1912 (2007).
5. Morita, E. et al. Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis. EMBO J. 26, 4215-4227 (2007).
6. Glotzer, M. The molecular requirements for cytokinesis. Science 307, 1735-1739 (2005).
7. Skop, A.R., Liu, H.B., Yates, J., Meyer, B.J. & Heald, R. Dissection of the mammalian midbody proteome reveals conserved cytokinesis mechanisms. Science 305, 61-66 (2004).
8. Gromley, A. et al. Centriolin anchoring of exocyst and SNARE complexes at the midbody is required for secretory-vesicle-mediated abscission. Cell 123, 75-87 (2005).
9. Pohl, C. & Jentsch, S. Final stages of cytokinesis and midbody ring formation are controlled by BRUCE. Cell 132, 832-845 (2008).
10. Hanson, P.I., Roth, R., Lin, Y. & Heuser, J.E. Plasma membrane deformation by circular arrays of ESCRT-III protein filaments. J. Cell Biol. 180, 389-402 (2008).
11. Lata, S. et al. Helical structures of ESCRT-III are disassembled by VPS4. Science 321, 1354-1357 (2008).
12. Dukes, J.D., Richardson, J.D., Simmons, R. & Whitley, P. A dominant-negative ESCRT-III protein perturbs cytokinesis and trafficking to lysosomes. Biochem. J. 411, 233-239 (2008).
13. Hurley, J.H. & Yang, D. MIT domainia. Dev. Cell 14, 6-8 (2008).
14. Stuchell-Brereton, M.D. et al. ESCRT-III recognition by VPS4 ATPases. Nature 449, 740-744 (2007).
15. Obita, T. et al. Structural basis for selective recognition of ESCRT-III by the AAA ATPase Vps4. Nature 449, 735-739 (2007).
16. Reid, E. et al. The hereditary spastic paraplegia protein spastin interacts with the ESCRT-III complex-associated endosomal protein CHMP1B. Hum. Mol. Genet. 14, 19-38 (2005).
17. Soderblom, C. & Blackstone, C. Traffic accidents: molecular genetic insights into the pathogenesis of the hereditary spastic paraplegias. Pharmacol. Ther. 109, 42-56 (2006).
18. Roll-Mecak, A. & Vale, R.D. Structural basis of microtubule severing by the hereditary spastic paraplegia protein spastin. Nature 451, 363-367 (2008).
19. Errico, A., Claudiani, P., D'Addio, M. & Rugarli, E.I. Spastin interacts with the centrosomal protein NA14, and is enriched in the spindle pole, the midbody and the distal axon. Hum. Mol. Genet. 13, 2121-2132 (2004).
20. Carlton, J.G., Agromayor, M. & Martin-Serrano, J. Differential requirements for Alix and ESCRT-III in cytokinesis and HIV-1 release. Proc. Natl. Acad. Sci. USA 105, 10541-10546 (2008).
21. Zamborlini, A. et al. Release of autoinhibition converts ESCRT-III components into potent inhibitors of HIV-1 budding. Proc. Natl. Acad. Sci. USA 103, 19140-19145 (2006).
22. Shim, S., Kimpler, L.A. & Hanson, P.I. Structure/function analysis of four core ESCRT-III proteins reveals common regulatory role for extreme C-terminal domain. Traffic 8, 1068-1079 (2007).
23. Lata, S. et al. Structural basis for autoinhibition of ESCRT-III CHMP3. J. Mol. Biol. 378, 818-825 (2008).
24. Xiao, J. et al. Structural basis of Vta1 function in the multi-vesicular body sorting pathway. Dev. Cell 14, 37-49 (2008).
25. Azmi, I.F. et al. ESCRT-III family members stimulate Vps4 ATPase activity directly or via Vta1. Dev. Cell 14, 50-61 (2008).
26. Shim, S., Merrill, S.A. & Hanson, P.I. Novel interactions of ESCRT-III with LIP5 and VPS4 and their implications for ESCRT-III disassembly. Mol. Biol. Cell 19, 2661-2672 (2008).
27. Tsang, H.T.H. et al. A systematic analysis of human CHMP protein interactions: additional MIT domain-containing proteins bind to multiple components of the human ESCRT III complex. Genomics 88, 333-346 (2006).
28. Agromayor, M. & Martin-Serrano, J. Interaction of AMSH with ESCRT-III and deubiquitination of endosomal cargo. J. Biol. Chem. 281, 23083-23091 (2006).
29. Ma, Y.M. et al. Targeting of AMSH to endosomes is required for epidermal growth factor degradation. J. Biol. Chem. 282, 9805-9812 (2007).
30. Row, P.E. et al. The MIT domain of UBPY constitutes a CHMP binding and endosomal localization signal required for efficient EGF receptor degradation. J. Biol. Chem. 282, 30929-30937 (2007).
31. Kieffer, C. et al. Two distinct modes of ESCRT-III recognition are required for VPS4 functions in lysosomal protein targeting and HIV-1 budding. Dev. Cell 15, 62-73 (2008).
32. Blackstone, C., Roberts, R.G., Seeburg, D.P. & Sheng, M. Interaction of the deafness-dystonia protein DDP/TIMM8a with the signal transduction adaptor molecule STAM1. Biochem. Biophys. Res. Commun. 305, 345-352 (2003).
33. Yu, W. et al. The microtubule-severing proteins spastin and katanin participate differently in the formation of axonal branches. Mol. Biol. Cell 19, 1485-1498 (2008).
34. Studier, F.W. Protein production by auto-induction in high-density shaking cultures. Protein Expr. Purif. 41, 207-234 (2005).
35. Terwilliger, T.C. & Berendzen, J. Automated MAD and MIR structure solution. Acta Crystallogr. D Biol. Crystallogr. 55, 849-861 (1999).
36. Terwilliger, T.C. Maximum-likelihood density modification. Acta Crystallogr. D Biol. Crystallogr. 56, 965-972 (2000).
37. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132 (2004).
38. Brunger, A.T. et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54, 905-921 (1998).
39. Murshudov, G.N., Vagin, A.A. & Dodson, E.J. Refinement of macromolecular structures by the maximum- likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53, 240-255 (1997).